Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Elpamotide |
| Trade Name | |
| Synonyms | VEGFR2-169 |
| Drug Descriptions |
Elpamotide (VEGFR2-169) is a KDR (VEGFR2) HLA-A*2402 allele specific peptide vaccine, which may stimulate cytotoxic T cell response against tumor cells expressing VEGFR2 (KDR) (PMID: 25867139, PMID: 25502982). |
| DrugClasses | |
| CAS Registry Number | 673478-49-4 |
| NCIT ID | C74090 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Elpamotide | Elpamotide | 0 | 0 |
| Elpamotide + Gemcitabine | Elpamotide Gemcitabine | 0 | 0 |
| Elpamotide + VEGFR1-1084 | Elpamotide VEGFR1-1084 | 0 | 0 |